An Efficacy, Safety, and Tolerability Study of Canagliflozin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy
Clinical trial NCT01340664 · COMPLETED
Trial details
- NCT number
- NCT01340664
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2012-04-01
- Enrollment
- 279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.